The effect of timing on gliclazide absorption and action

Area of Science:

• Endocrinology
• Pharmacology
• Metabolic Disorders

Background:

• Gliclazide is a sulfonylurea medication used to manage type 2 diabetes by stimulating insulin release.
• Optimal timing of gliclazide administration in relation to meals is crucial for maximizing its glucose-lowering effects.
• Understanding the pharmacokinetic and pharmacodynamic profile of gliclazide is essential for effective glycemic control.

Purpose of the Study:

• To determine the optimal timing for administering gliclazide relative to meals for enhanced hypoglycemic efficacy.
• To investigate the impact of different administration timings (30 minutes before, immediately before, or immediately after breakfast) on serum gliclazide, glucose, and insulin levels.

Main Methods:

• Eight non-insulin-dependent diabetic patients participated in a controlled study during hospitalization.
• Patients received a 40 mg gliclazide tablet at three different times relative to breakfast over consecutive days.
• Serum gliclazide, glucose, and insulin (IRI) levels were measured at 30-minute intervals for 2.5 hours around breakfast.

Main Results:

• Gliclazide taken 30 minutes before breakfast led to higher serum concentrations prior to meal-induced hyperglycemia.
• Administration immediately before or after breakfast resulted in poor absorption, delayed peaks, and reduced efficacy.
• Taking gliclazide 30 minutes before breakfast synchronized insulin release with postprandial glucose spikes, mitigating prolonged hyperglycemia.

Conclusions:

• Gliclazide is most effective when administered 30 minutes before breakfast to optimize absorption and hypoglycemic action.
• Taking gliclazide immediately before or after meals leads to suboptimal glycemic control due to delayed absorption and insulin response.
• This study provides evidence-based recommendations for improving gliclazide therapy in diabetic patients.